ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2015
Authors' reply to Srinivas: "pharmacokinetics and tolerability of the novel oral prostacyclin IP receptor agonist selexipag".
Priska Kaufmann et al.PubMed ↗Publisher ↗
No numbers read from the abstract.